VYGR
Voyager Therapeutics Inc.
Company Overview
| Mkt Cap | $236.85M | Price | $4.67 |
| Volume | 319.10K | Change | +3.32% |
| P/E Ratio | -3.6 | Open | $4.49 |
| Revenue | $80.0M | Prev Close | $4.52 |
| Net Income | $-65.0M | 52W Range | $2.65 - $7.44 |
| Div Yield | N/A | Target | $15.08 |
| Overall | 49 | Value | 60 |
| Quality | 44 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyVoyager Therapeutics Inc. (VYGR) is a leading Healthcare company in the Biotechnology industry, currently trading at $4.67 with a market capitalization of $236.85 million. The stock is trading in the middle of its 52-week range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows VYGR with a volume of 319K shares. The stock opened down 0.66% from yesterday's close of $4.52. Current analyst estimates project earnings of $-2.14 per share for this year, with next year targeting $-1.41.
VYGR demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for VYGR include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 222.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VYGR | $4.67 | +3.3% | 319.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Voyager Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW